Home   About this service   Get the news  
+32 2 743 34 03

 Belgium  Other Countries
Page : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - ...
Gimv [BE0003699130/GIMB]   
[04/12/2019]

Gimv : Imcheck Therapeutics raises USD 53 million, Gimv increases its investment in the immuno-oncology space

Antwerp/Marseille, 4 December 2019, 6:45 AM CET Imcheck Therapeutics raises USD 53 million, Gimv increases its investment in the immunooncology space In a Series B financing round of USD 53 million, Gimv is increasing its investment in French ImCheck Therapeutics www.imchecktherapeutics.com, an emerging player in the field of cancer and autoimmune ... See more
 
Gimv [BE0003699130/GIMB]   
[21/11/2019]

Gimv : Further growth and continuing strong portfolio results

Antwerp, 21 November 2019, 7:00 CET Further growth and continuing strong portfolio results Managing Director Koen Dejonckheere, on the past halfyears results: “With a persistent strong pace of investment, Gimv grew its portfolio further to its present level of EUR 1.2 billion. Our portfolio companies achieved attractive results in an uncertain... See more
 
Gimv [BE0003699130/GIMB]   
[14/10/2019]

Gimv : Eric de Montgolfier appointed as CEO of Invest Europe

Antwerpen / Paris, 14 October 2019, 8:00 CET Eric de Montgolfier appointed as CEO of Invest Europe 14 October 2019, Invest Europe appoints Eric de Montgolfier as new CEO to lead the world’s largest association of private capital providers and investors. We sincerely thank Eric currently Head Gimv France for the past 5 years at Gimv and wish him all the best... See more
 
Gimv [BE0003699130/GIMB]   
[05/09/2019]

Gimv : iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment

Antwerp, 5 September, 8:00 AM CET iSTAR Medical announces EUR 40.1 million financing round lead by Gimv to support further development of an innovative glaucoma treatment iSTAR Medical SA, a Wavrebased private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announces the completion of a EUR 40.1... See more
 
Gimv [BE0003699130/GIMB]   
[30/07/2019]

Gimv : AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection.

Antwerp BE, 30 July 2019, 8:00 CET AgroSavfe raises EUR 35 million, Gimv invests additional resources for further development of biocontrols as a new standard for sustainable crop protection Gimv is increasing its commitment to AgroSavfe, an innovative food and agrobiotech company developing environmentally friendly plant protection products. As... See more